Re: Urgent appeal to initiate delamanid compassionate use program

Second in a series of symposia calling for Zero TB Deaths, New Infections, and Suffering.

Approval of and access to delamanid are crucial while further research is pending.

Colleen Daniels of Treatment Action Group challenged the delegates assembled to be more ambitious and aim for zero TB deaths, zero new infections and zero suffering and stigma.

As threat of drug-resistance grows, Big Pharma decreases investments in TB research by 22 percent.

2013 International Union Against TB and Lung Disease World Conference
Date: 1 November 2013
Time: 18h00 - 22h00
Location: Hôtel Concorde La Fayette, Batignolles/Longchamp Room, 3, Place du Général Koenig, 75850 Paris Cedex 17

Cost to end deaths from childhood TB estimated to be at least US$120 million annually.

The World Health Organization, The Union, the Stop TB Partnership, USAID, CDC, the Treatment Action Group and UNICEF will launch a roadmap outlining the path towards zero deaths from childhood tuberculosis.

Re: Responsible marketing and access plans for Alere’s Determine TB-­LAM antigen test for active TB

Approval of and access to delamanid is crucial while further research is pending.